Article

Optos ships next-generation imaging devices

Medical retinal imaging company Optos plc has delivered its first next-generation ultra-widefield retinal imaging devices (Daytona) to customers. The new devices have been scaled to accommodate smaller office spaces while providing high-resolution imaging and adding new autofluorescence capabilities.

London-Medical retinal imaging company Optos plc has delivered its first next-generation ultra-widefield retinal imaging devices (Daytona) to customers. The new devices have been scaled to accommodate smaller office spaces while providing high-resolution imaging and adding new autofluorescence capabilities.

According to Optos, the devices feature a new, ergonomic body designed to increase patient comfort as well as make it easier to position the eye correctly; an improved user interface with an intuitive, workflow-based software; “plug-and-play” installation; image review capabilities; and electronic image storage options. The device was designed to allow the globalization of the company’s core imaging technology.

“We are pleased to announce shipment of our first devices on schedule,” said Roy Davis, chief executive officer, Optos plc. “Following the unveiling of [the next-generation devices] in October, we have seen growing demand for the product, and over the coming months we will be increasing our manufacturing capacity accordingly. We believe [these devices] represent an excellent growth opportunity for Optos.”

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Parag Majmudar, MD, on bridging the gap between residency and real-world practice
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
Abby Markward discusses the ASCRS Foundation and the ASCRS Annual Meeting
(Image credit: Ophthalmology Times) Inside ASCRS 2025: Francis S. Mah, MD, takes the helm with a vision for research, education, and advocacy
© 2025 MJH Life Sciences

All rights reserved.